Kyndryl faces securities class action over financial reporting deficiencies

GlobeNewswire Inc.GlobeNewswire Inc.
|||1 min read
Key Takeaway

Kyndryl Holdings faces securities lawsuit alleging false financial statements and inadequate internal controls, with shareholders from August 2024-February 2026 eligible to join the class action.

Kyndryl faces securities class action over financial reporting deficiencies

The Gross Law Firm has initiated a securities class action lawsuit against Kyndryl Holdings, Inc. (NYSE: KD), alleging the company made materially false and misleading statements regarding its financial condition and internal control mechanisms. The litigation encompasses the period from August 7, 2024 through February 9, 2026, during which the company allegedly failed to maintain adequate internal controls and was unable to file quarterly reports in a timely manner.

The lawsuit targets shareholders who invested in Kyndryl during the specified class period and seeks to hold the company accountable for alleged disclosure failures. According to the complaint, the company's financial statements did not accurately reflect its operational challenges, particularly regarding its ability to meet regulatory filing deadlines.

Shareholders who purchased Kyndryl stock during the class period have until April 13, 2026 to register their claims with The Gross Law Firm. The deadline represents a key date for investors seeking to participate in the legal action or explore their options regarding potential losses.

Source: GlobeNewswire Inc.

Back to newsPublished Feb 18

Related Coverage

GlobeNewswire Inc.

FSK Securities Fraud Lawsuit: Investors Sought for Class Action Over Misleading Statements

Schall Law Firm seeks $FSK investors for class action lawsuit alleging false statements on portfolio restructuring, valuations, and dividend strength between May 2024 and February 2026.

FSK
GlobeNewswire Inc.

Securities Fraud Investigations Target LKQ, Molina, MongoDB, and Power Solutions

Grabar Law Office investigates four companies for alleged securities fraud involving false statements about business performance, causing stock price inflation and investor losses.

MOHLKQMDB
GlobeNewswire Inc.

POET Technologies Hit with Securities Fraud Lawsuit Over PFIC Disclosure Failures

Kirby McInerney LLP files class action against POET Technologies for alleged securities fraud involving PFIC misrepresentation and confidentiality breaches, triggering steep stock declines.

POET
GlobeNewswire Inc.

LakeShore Biopharma Faces Securities Probe Over Alleged Misleading Statements

The Schall Law Firm investigates LakeShore Biopharma for alleged securities violations, including false statements and material information failures, recruiting affected shareholders.

LSBCF
GlobeNewswire Inc.

CCRN Under Investigation for Alleged Securities Violations

Schall Law Firm investigates Cross Country Healthcare ($CCRN) for alleged securities violations involving false statements or material disclosure failures to investors.

CCRN
GlobeNewswire Inc.

Immutep Faces Class Action Over $IMMP Trial Failure; Investors Have Days to Join Lawsuit

Immutep faces class action lawsuit alleging investor deception over TACTI-004 trial failure. Stock plunged 83% after March discontinuation announcement, despite positive January guidance. Lead plaintiff deadline: July 6, 2026.

IMMP